SBI Securities »

Akari Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Akari Therapeutics shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Akari Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $26 5 5.20

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Tesla Motors (TSLA)
Alphabet Inc Class A cs (GOOGL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
SPDR Gold MiniShares Trust Etf (GLDM)
Alphabet Inc Class C cs (GOOG)

View all positions for SBI Securities

Top funds holding Akari Therapeutics

Armistice Capital
Cresset Asset Management
IFP Advisors
SBI Securities
Morgan Stanley
Truvestments Capital

View all funds holding Akari Therapeutics